Keyphrases
Cancer Cells
100%
Highly Sensitive
100%
Kinase Activity
100%
Abl Kinase
100%
Mitoxantrone
100%
C-Abl
100%
Small Interfering RNA (siRNA)
28%
DNA Damage
28%
Apoptosis
28%
HeLa Cells
28%
Imatinib
28%
Chemotherapy Drugs
28%
Combination Treatment
14%
Cell Survival
14%
Cancer Cell Lines
14%
Cancer Chemotherapy
14%
Cytotoxic Effect
14%
Induced Apoptosis
14%
Cell Cycle Progression
14%
SiRNA Knockdown
14%
Doxorubicin
14%
G2 Phase
14%
High-risk Human Papillomavirus (HR-HPV)
14%
Imatinib Therapy
14%
Treatment Results
14%
DNA Damage Response
14%
Caspase Activation
14%
Transcriptionally Active
14%
Combinational Therapy
14%
Primary Fibroblasts
14%
Potentiation
14%
Cell-less
14%
P53 Activity
14%
INIS
inhibition
100%
dna damages
100%
cancer
100%
kinases
100%
apoptosis
100%
chemotherapy
100%
drugs
66%
hela cells
66%
comparative evaluations
33%
rna
33%
humans
33%
panels
33%
death
33%
fibroblasts
33%
cell cycle
33%
augmentation
33%
doxorubicin
33%
Pharmacology, Toxicology and Pharmaceutical Science
Mitoxantrone
100%
Malignant Neoplasm
100%
Abelson Kinase
100%
Protein P53
66%
Imatinib
50%
Chemotherapy
33%
Small Interfering RNA
33%
Doxorubicin
16%
Human Papillomavirus
16%
Cancer Chemotherapy
16%
Phosphotransferase
16%
Caspase
16%
Cytotoxicity
16%